{
    "Trade/Device Name(s)": [
        "ST AIA-PACK Intact PTH",
        "ST AIA-PACK Intact PTH CALIBRATOR SET",
        "AIA-PACK Intact PTH CONTROL SET"
    ],
    "Submitter Information": "Tosoh Bioscience, Inc.",
    "510(k) Number": "K063605",
    "Predicate Device Reference 510(k) Number(s)": [
        "K992680"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CEW",
        "JIT",
        "JJX"
    ],
    "Summary Letter Date": "June 21, 2007",
    "Summary Letter Received Date": "June 20, 2007",
    "Submission Date": "June 13, 2007",
    "Regulation Number(s)": [
        "21 CFR 862.1545"
    ],
    "Regulation Name(s)": [
        "Parathyroid hormone test system"
    ],
    "Analyte Class(es)": [
        "endocrine"
    ],
    "Analyte(s)": [
        "Parathyroid hormone"
    ],
    "Specimen Type(s)": [
        "Serum",
        "EDTA Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "TOSOH AIA System analyzers"
    ],
    "Method(s)/Technology(ies)": [
        "Two-site immunoenzymometric assay (IEMA)"
    ],
    "Methodologies": [
        "Immunoenzymometric assay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Tosoh Bioscience ST AIA-PACK Intact PTH Assay for quantitative measurement of parathyroid hormone in serum and EDTA plasma using immunoenzymometric technology",
    "Indications for Use Summary": "Intended for in vitro quantitative measurement of parathyroid hormone in human serum and EDTA plasma to aid in the differential diagnosis of hypercalcemia and hypocalcemia due to disorders of calcium metabolism",
    "fda_folder": "Clinical Chemistry"
}